These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36109399)

  • 1. Dose-effect relationship between dose-volume parameters of residual gross tumor volume and clinical prognosis in MRI-guided adaptive brachytherapy for locally advanced cervical cancer: a single-center retrospective study.
    Ke T; Wang J; Zhang N; Zhao H; Guo X; Zhao Z; Mao Z; Cheng G
    Strahlenther Onkol; 2023 Feb; 199(2):131-140. PubMed ID: 36109399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
    Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
    Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Image-guided adaptive brachytherapy for advanced cervical cancer spreading to the bladder and/or rectum: Clinical outcome and prognostic factors.
    Ka K; Laville A; Rassy E; Ayachi RE; Pautier P; Ba MB; Bockel S; Achkar S; Espenel S; Maulard A; Morice P; Gouy S; Haie-Meder C; Sun R; Chargari C
    Gynecol Oncol; 2023 Jan; 168():32-38. PubMed ID: 36370612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of dose-effect relationship between DVH parameters and clinical prognosis of definitive radio(chemo)therapy combined with intracavitary/interstitial brachytherapy in patients with locally advanced cervical cancer: A single-center retrospective study.
    Zhang N; Tang Y; Guo X; Mao Z; Yang W; Cheng G
    Brachytherapy; 2020; 19(2):194-200. PubMed ID: 31791712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
    Schmid MP; Lindegaard JC; Mahantshetty U; Tanderup K; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza A; Hoskin P; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Petric P; Ramazanova D; Ristl R; Kannan S; Hawaldar R; Ecker S; Kirchheiner K; Tan LT; Nout R; Nesvacil N; de Leeuw A; Pötter R; Kirisits C;
    J Clin Oncol; 2023 Apr; 41(10):1933-1942. PubMed ID: 36599120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
    Wu PY; Wong TPW; Yip YYC; Chang TYA; Chan LKL; Lee MCH; Law LYA; Yeung MWR; Soong SI
    Brachytherapy; 2019; 18(2):171-179. PubMed ID: 30581053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Outcomes of MRI-Guided Adaptive Brachytherapy for Each Fraction in Locally Advanced Cervical Cancer: A Single Institution Experience.
    Chi Y; Pan Y; Zhang N; Han D; Guo X; Mao Z; Cheng G
    Front Oncol; 2022; 12():841980. PubMed ID: 35372065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety and efficacy of volumetric modulated Arc therapy combined with computer tomography-guided adaptive brachytherapy for locally advanced cervical cancer: a single institution experience.
    Yang T; Zhao T; Ji Z; Lei R; Qu A; Jiang W; Deng X; Jiang P
    Radiat Oncol; 2024 Jun; 19(1):77. PubMed ID: 38909242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A volumetric analysis of GTV
    Jastaniyah N; Yoshida K; Tanderup K; Lindegaard JC; Sturdza A; Kirisits C; Šegedin B; Mahantshetty U; Rai B; Jürgenliemk-Schulz IM; Haie-Meder C; Banerjee S; Pötter R;
    Radiother Oncol; 2016 Sep; 120(3):404-411. PubMed ID: 27452409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic effect of tumor volume, reduction ratio, and cumulative doses on external beam radiotherapy with central-shielding method and image-guided adaptive brachytherapy for cervical cancer.
    Ohtaka T; Ando K; Oike T; Noda SE; Kaminuma T; Murata K; Ohno T
    Front Oncol; 2024; 14():1366777. PubMed ID: 38774419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome and dosimetric parameters of chemo-radiation including MRI guided adaptive brachytherapy with tandem-ovoid applicators for cervical cancer patients: a single institution experience.
    Nomden CN; de Leeuw AA; Roesink JM; Tersteeg RJ; Moerland MA; Witteveen PO; Schreuder HW; van Dorst EB; Jürgenliemk-Schulz IM
    Radiother Oncol; 2013 Apr; 107(1):69-74. PubMed ID: 23639580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MRI-guided two adaptive brachytherapy fractions versus one adaptive brachytherapy fraction in one application for the cervical cancer: a retrospective study.
    Song S; Han D; Zhang N; Mao Z; Guo X; Cheng G
    Radiat Oncol; 2023 Mar; 18(1):46. PubMed ID: 36879287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local recurrences in cervical cancer patients in the setting of image-guided brachytherapy: a comparison of spatial dose distribution within a matched-pair analysis.
    Schmid MP; Kirisits C; Nesvacil N; Dimopoulos JC; Berger D; Pötter R
    Radiother Oncol; 2011 Sep; 100(3):468-72. PubMed ID: 21924510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical efficacy and toxicity of radio-chemotherapy and magnetic resonance imaging-guided brachytherapy for locally advanced cervical cancer patients: A mono-institutional experience.
    Lakosi F; de Cuypere M; Viet Nguyen P; Jansen N; Warlimont B; Gulyban A; Gennigens C; Seidel L; Delbecque K; Coucke P; Hermesse J; Kridelka F
    Acta Oncol; 2015; 54(9):1558-66. PubMed ID: 26406152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
    Pötter R; Tanderup K; Schmid MP; Jürgenliemk-Schulz I; Haie-Meder C; Fokdal LU; Sturdza AE; Hoskin P; Mahantshetty U; Segedin B; Bruheim K; Huang F; Rai B; Cooper R; van der Steen-Banasik E; Van Limbergen E; Pieters BR; Tan LT; Nout RA; De Leeuw AAC; Ristl R; Petric P; Nesvacil N; Kirchheiner K; Kirisits C; Lindegaard JC;
    Lancet Oncol; 2021 Apr; 22(4):538-547. PubMed ID: 33794207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-volume parameters and local tumor control in cervical cancer treated with central-shielding external-beam radiotherapy and CT-based image-guided brachytherapy.
    Okazaki S; Murata K; Noda SE; Kumazaki Y; Hirai R; Igari M; Abe T; Komatsu S; Nakano T; Kato S
    J Radiat Res; 2019 Jul; 60(4):490-500. PubMed ID: 31111896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome of protocol based image (MRI) guided adaptive brachytherapy combined with 3D conformal radiotherapy with or without chemotherapy in patients with locally advanced cervical cancer.
    Pötter R; Georg P; Dimopoulos JC; Grimm M; Berger D; Nesvacil N; Georg D; Schmid MP; Reinthaller A; Sturdza A; Kirisits C
    Radiother Oncol; 2011 Jul; 100(1):116-23. PubMed ID: 21821305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of locally advanced vaginal cancer with radiochemotherapy and magnetic resonance image-guided adaptive brachytherapy: dose-volume parameters and first clinical results.
    Dimopoulos JC; Schmid MP; Fidarova E; Berger D; Kirisits C; Pötter R
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1880-8. PubMed ID: 21868174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vienna-II ring applicator for distal parametrial/pelvic wall disease in cervical cancer brachytherapy: An experience from two institutions: Clinical feasibility and outcome.
    Mahantshetty U; Sturdza A; Naga Ch P; Berger D; Fortin I; Motisi L; Schmid MP; Aravindakshan D; Ghadi Y; Swamidas JV; Chopra S; Gurram L; Nesvacil N; Kirisits C; Pötter R
    Radiother Oncol; 2019 Dec; 141():123-129. PubMed ID: 31495516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.